Anika Therapeutics (ANIK)
(Real Time Quote from BATS)
$25.42 USD
-0.12 (-0.47%)
Updated Mar 28, 2024 11:42 AM ET
2-Buy of 5 2
C Value A Growth A Momentum A VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 32% (80 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.00 | 1.35 | 9.99 |
Current Quarter Estimate | -0.19 | 7.43 | 59.00 |
Year Ago Quarter Estimate | -0.71 | 0.12 | 50.37 |
Next Quarter Estimate | 0.00 | 7.81 | 60.00 |
Next Year Estimate | -0.01 | 37.76 | 250.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 96.45 | 12.70 | 26.94 |
Next Year | 95.00 | 10.10 | 8.00 |
Last 5 Years | -168.60 | 1.00 | 9.00 |
Next 5 Years | 10.00 | 20.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 1.76 | 2.24 |
Price/Cash Flow (MRFY) | 5.19 | 14.17 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -49.60% | -160.91% |
Return on Equity (TTM) | -2.10% | -52.31% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.